$29.37
-0.25-0.84%
At close: -
$29.37
0.000.00%
After Hours: Mar 7, 4:00 PM EDT
Comments
Loading...
Surmodics Stock Guidance | NASDAQ:SRDX | Benzinga
Surmodics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Surmodics (SRDX)?
The most recent guidance for Surmodics (SRDX) was reported on May 1, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $-0.67 to $-0.47, compared to the estimated EPS of $-0.94. Additionally, Surmodics forecasted revenue between $0.12B and $0.12B for the quarter.
Browse guidance and forecast on all stocks.